{"id":106484,"name":"FRESENIUS MEDICAL CARE","slug":"fresenius-medical-care","state":null,"description":null,"totalSpending":1500000,"filings":25,"yearlySpending":[{"year":2018,"income":240000},{"year":2019,"income":240000},{"year":2020,"income":180000},{"year":2021,"income":180000},{"year":2022,"income":240000},{"year":2024,"income":240000},{"year":2025,"income":180000}],"firms":["BGR GOVERNMENT AFFAIRS"],"lobbyists":["ROBERT WOOD","DAVID BOYER","JENNIFER LUKAWSKI","ROBB WALTON","MATT HOFFMANN","DANIEL FARMER","RAGHAV AGGARWAL"],"issues":["HCR"],"sampleDescriptions":["Medicare reimbursement; End stage renal disease payment reforms; implementation of health care reform; third party payments","Medicare reimbursement; End stage renal disease payment reforms; implementation of health care reform; third party payments; CMS payment regulations impacting vascular access clinics and ASCs","Medicare reimbursement; End stage renal disease payment reforms; implementation of health care reform; third party payments; CMS shared savings plans","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; implementation of CARES Act; third party payments; access to Medicare Advantage plans for ESRD patients","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; implementation of CARES Act; vaccine distribution; extension of medicine sequester; telehealth policy and waivers","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; implementation of CARES Act; COVID vaccination policy; extension of medicine sequester; telehealth policy and waivers","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; implementation of CARES Act; COVID vaccination policy; extension of medicine sequester; telehealth policy and waivers; Provider Relief Fund","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; implementation of CARES Act; COVID vaccination policy; extension of medicine sequester; telehealth policy and waivers; Provider Relief Fund; issues pertaining to Medicare Secondary Payer Act","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; extension of Medicare sequester; telehealth policy and waivers; issues pertaining to Medicare Secondary Payer Act","Medicare reimbursement; End stage renal disease (ESRD) payment reforms; extension of Medicare sequester; telehealth policy and waivers; issues pertaining to Medicare Secondary Payer Act; oral-only ESRD drugs"],"years":[2018,2019,2020,2021,2022,2024,2025]}